Select Medical (NYSE:SEM) Price Target Cut to $23.00 by Analysts at Royal Bank of Canada

Select Medical (NYSE:SEM - Get Free Report) had its target price lowered by stock analysts at Royal Bank of Canada from $47.00 to $23.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has an "outperform" rating on the health services provider's stock. Royal Bank of Canada's target price points to a potential upside of 24.48% from the stock's current price.

Several other brokerages also recently commented on SEM. StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective for the company in a report on Monday. Finally, UBS Group cut their target price on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $27.25.

Select Medical Stock Down 0.1 %

Shares of SEM stock traded down $0.02 on Monday, hitting $18.48. The company's stock had a trading volume of 937,645 shares, compared to its average volume of 900,120. Select Medical has a fifty-two week low of $16.20 and a fifty-two week high of $40.98. The firm's fifty day moving average price is $19.07 and its 200-day moving average price is $27.65. The stock has a market capitalization of $2.38 billion, a price-to-earnings ratio of 11.20, a P/E/G ratio of 0.64 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last posted its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. Research analysts anticipate that Select Medical will post 1.17 EPS for the current year.

Insider Buying and Selling at Select Medical

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm's stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 17.50% of the company's stock.

Institutional Investors Weigh In On Select Medical

A number of institutional investors and hedge funds have recently made changes to their positions in SEM. Vanguard Group Inc. raised its holdings in shares of Select Medical by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider's stock valued at $239,640,000 after purchasing an additional 131,228 shares during the period. Dimensional Fund Advisors LP raised its stake in Select Medical by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider's stock valued at $83,533,000 after buying an additional 62,585 shares during the period. Invesco Ltd. lifted its holdings in Select Medical by 48.6% during the 4th quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock valued at $49,838,000 after purchasing an additional 864,852 shares during the last quarter. Geode Capital Management LLC grew its stake in Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider's stock valued at $85,180,000 after buying an additional 46,880 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in Select Medical by 1.9% in the 4th quarter. Principal Financial Group Inc. now owns 2,403,508 shares of the health services provider's stock valued at $45,310,000 after purchasing an additional 45,685 shares during the period. Institutional investors own 89.48% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.